Page last updated: 2024-08-23

etoposide and Parkinson Disease, Secondary

etoposide has been researched along with Parkinson Disease, Secondary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fleming, DR; Mangino, PB	1

Other Studies

1 other study(ies) available for etoposide and Parkinson Disease, Secondary

Article	Year
Parkinsonian syndrome in a dialysis-supported patient receiving high-dose chemotherapy for multiple myeloma. Southern medical journal, 1997, Volume: 90, Issue:3 Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Hemofiltration; Humans; Immunoglobulin kappa-Chains; Male; Middle Aged; Multiple Myeloma; Parkinson Disease, Secondary; Renal Insufficiency	1997

Article

Year

Parkinsonian syndrome in a dialysis-supported patient receiving high-dose chemotherapy for multiple myeloma.

Southern medical journal, 1997, Volume: 90, Issue:3

Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Hemofiltration; Humans; Immunoglobulin kappa-Chains; Male; Middle Aged; Multiple Myeloma; Parkinson Disease, Secondary; Renal Insufficiency

1997